Q2 FY2026 · ended Jun 30, 2026 · Revenue $743.17M, +55.6% YoY · Filed Aug 7, 2026
Clover Health Investments, Corp. /DE (CLOV) files with the SEC under industry code 6324, Hospital & Medical Service Plans. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $743.2 million and net income of $28.0 million. Free cash flow was $24.5 million.
Revenue
$743.17M
+55.6% vs year-ago quarter
Net income
$28.00M
+364.7% vs year-ago quarter
Operating cash flow
$25.19M
+365.8% vs year-ago quarter
Free cash flow
$24.51M
+406.4% vs year-ago quarter
EPS
$0.05
+0.0% vs prior quarter
Dividend per share
None
Shares outstanding
—
Net cash
$285.23M
Q4 FY2025
Operating margin
-0.7%
TTM
Company profile
- Industry
- Hospital & Medical Service Plans (SIC 6324)
- Listed as
- CLOV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Jersey City, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1801170
- Former names
- Social Capital Hedosophia Holdings Corp. III (until Jan 7, 2021)
Other Hospital & Medical Service Plans companies
- Unitedhealth Group Inc UNH
- Elevance Health, Inc. ELV
- Cigna Group CI
- Humana Inc HUM
- Centene Corp CNC
- Molina Healthcare, Inc. MOH
- Oscar Health, Inc. OSCR
- Alignment Healthcare, Inc. ALHC
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
Q1 FY2025 Mar 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $743.2M | $749.2M | $496.6M | $477.6M | $462.3M |
| Operating income | $28.0M | $27.3M | -$24.4M | -$10.6M | -$1.3M |
| Net income | $28.0M | $27.3M | -$24.4M | -$10.6M | -$1.3M |
| Diluted EPS | $0.05 | $0.05 | — | — | — |
| Operating cash flow | $25.2M | $107.9M | $12.1M | $5.4M | -$16.3M |
| Free cash flow | $24.5M | $107.0M | $11.4M | $4.8M | -$16.5M |
| Total assets | $720.3M | $697.7M | $559.7M | $575.0M | $583.7M |
| Total liabilities | $344.1M | $358.3M | $218.7M | $230.8M | $247.6M |
| Stockholders' equity | $376.3M | $339.4M | — | — | — |
| Cash and investments | $428.0M | $399.7M | $381.7M | $375.0M | $376.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 4, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 9, 2026 | Oct 8, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 25, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 24, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
All 708 Clover Health Investments, Corp. /DE SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.